U.S. markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
54.27+0.12 (+0.22%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
Total Revenue
0
0
0
Operating Expense
36,426
14,608
9,477
Operating Income
-36,426
-14,608
-9,477
Net Non Operating Interest Income Expense
168
574
413
Pretax Income
-36,258
-14,034
-9,064
Net Income Common Stockholders
-36,258
-14,034
-9,064
Diluted NI Available to Com Stockholders
-36,258
-14,034
-9,064
Basic EPS
-
0
0
Diluted EPS
-
0
0
Basic Average Shares
-
43,737
43,737
Diluted Average Shares
-
43,737
43,737
Total Operating Income as Reported
-36,426
-14,608
-9,477
Total Expenses
36,426
14,608
9,477
Net Income from Continuing & Discontinued Operation
-36,258
-14,034
-9,064
Normalized Income
-36,258
-14,034
-9,064
Interest Income
168
574
413
Net Interest Income
168
574
413
EBIT
-36,426
-14,608
-9,477
EBITDA
-36,409
-
-
Reconciled Depreciation
17
17
17
Net Income from Continuing Operation Net Minority Interest
-36,258
-14,034
-9,064
Normalized EBITDA
-36,409
-14,591
-9,460
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0